Rajat Rawat, Pravesh Thapliyal, Raunak Kumar, Yogesh Joshi, Shobit Garg
{"title":"Beyond Pharmacology: Do Tablet Shape, Size, and Color Influence Medication Adherence in Psychiatric Outpatients?","authors":"Rajat Rawat, Pravesh Thapliyal, Raunak Kumar, Yogesh Joshi, Shobit Garg","doi":"10.4088/PCC.25m04101","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Medication nonadherence is a multifaceted challenge in psychiatric treatment, driven by clinical, psychosocial, and patient factors. An understudied aspect is the physical properties of solid oral dosage forms (SODFs)-shape, size, and color-which may influence acceptability and adherence. Yet, quantitative evidence connecting real-world preferences to adherence outcomes is scarce, especially in psychiatric settings.</p><p><p><b>Objective:</b> To evaluate preferences for tablet shape, size, and color among psychiatric outpatients and their relation to self-reported adherence.</p><p><p><b>Methods:</b> This cross-sectional observational study, conducted over 6 months (April-October 2024) in a tertiary psychiatric unit, included 232 patients with varied psychiatric diagnoses on oral medications. Sociodemographics, clinical details, and preferences/dislikes for tablet attributes (shape: flat circular vs oval/oblong; size: small, medium, large; color: white, yellow, red, blue) were gathered via a structured questionnaire. Adherence was measured using the validated 10-item Medication Adherence Rating Scale (score ≥6=adherent). Associations were analyzed with χ<sup>2</sup> and Fisher exact tests (<i>P</i><.05).</p><p><p><b>Results:</b> The cohort (mean age: 36±13.3 years; 65.1% male) had 74.1% adherence (95% CI, 68.1-79.3%). Preferences included oval/oblong shapes (43.5%), small sizes (41.4%), and white colors (41.8%); dislikes were large sizes (53.4%), flat-circular shapes (40.5%), and red colors (33.6%). No significant links existed between preferences/dislikes and adherence (all <i>P</i> >.05; χ<sup>2</sup> = 1.90-4.64; Cramér's V=0.09-0.14). Adherence rates varied by diagnosis (lowest in psychosis: 30.8%; 95% CI, 12.7-57.6% and highest in generalized anxiety disorder: 85.0%; 95% CI, 64.0-94.8%) but nonsignificantly (χ<sup>2</sup> =16.70, <i>P</i>= .081, Cramér's V=0.27).</p><p><p><b>Conclusion:</b> Psychiatric patients show distinct esthetic preferences for tablets, consistent with prior acceptability research, but these do not predict adherence. Clinical symptoms, illness insight, and therapeutic alliance appear to dominate. Strategies should emphasize psychosocial interventions rather than formulation esthetics.</p><p><p><i>Prim Care Companion CNS Disord</i> <i>2026;28(4):25m04101</i>.</p><p><p>\n <i>Author affiliations are listed at the end of this article.</i>\n </p>","PeriodicalId":22814,"journal":{"name":"The primary care companion for CNS disorders","volume":"28 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The primary care companion for CNS disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4088/PCC.25m04101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Medication nonadherence is a multifaceted challenge in psychiatric treatment, driven by clinical, psychosocial, and patient factors. An understudied aspect is the physical properties of solid oral dosage forms (SODFs)-shape, size, and color-which may influence acceptability and adherence. Yet, quantitative evidence connecting real-world preferences to adherence outcomes is scarce, especially in psychiatric settings.
Objective: To evaluate preferences for tablet shape, size, and color among psychiatric outpatients and their relation to self-reported adherence.
Methods: This cross-sectional observational study, conducted over 6 months (April-October 2024) in a tertiary psychiatric unit, included 232 patients with varied psychiatric diagnoses on oral medications. Sociodemographics, clinical details, and preferences/dislikes for tablet attributes (shape: flat circular vs oval/oblong; size: small, medium, large; color: white, yellow, red, blue) were gathered via a structured questionnaire. Adherence was measured using the validated 10-item Medication Adherence Rating Scale (score ≥6=adherent). Associations were analyzed with χ2 and Fisher exact tests (P<.05).
Results: The cohort (mean age: 36±13.3 years; 65.1% male) had 74.1% adherence (95% CI, 68.1-79.3%). Preferences included oval/oblong shapes (43.5%), small sizes (41.4%), and white colors (41.8%); dislikes were large sizes (53.4%), flat-circular shapes (40.5%), and red colors (33.6%). No significant links existed between preferences/dislikes and adherence (all P >.05; χ2 = 1.90-4.64; Cramér's V=0.09-0.14). Adherence rates varied by diagnosis (lowest in psychosis: 30.8%; 95% CI, 12.7-57.6% and highest in generalized anxiety disorder: 85.0%; 95% CI, 64.0-94.8%) but nonsignificantly (χ2 =16.70, P= .081, Cramér's V=0.27).
Conclusion: Psychiatric patients show distinct esthetic preferences for tablets, consistent with prior acceptability research, but these do not predict adherence. Clinical symptoms, illness insight, and therapeutic alliance appear to dominate. Strategies should emphasize psychosocial interventions rather than formulation esthetics.
Prim Care Companion CNS Disord2026;28(4):25m04101.
Author affiliations are listed at the end of this article.
期刊介绍:
Founded in 1998, The Primary Care Companion for CNS Disorders (ISSN 2155-7780), formerly The Primary Care Companion to The Journal of Clinical Psychiatry, is an international, peer-reviewed, online-only journal, and its articles are indexed by the National Library of Medicine. PCC seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses. PCC publishes research from disciplines such as medicine, nursing, pharmacy, and psychology, especially as it pertains to integrated delivery systems and interdisciplinary collaboration. PCC focuses on providing information of direct clinical utility and giving a voice to clinician researchers. Practice-based research from individuals and groups with clinical expertise is particularly welcome. Pertinent manuscript types include: -Original research -Systematic reviews -Meta-analyses -Case reports and series -Commenting letters to the editor Articles published in PCC typically cover attention-deficit/hyperactivity disorder, depression, bipolar disorder, anxiety, addiction, sleep disorders, pain, Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease.